9 Eurocare Lutz
-
Upload
mastermv2013 -
Category
Documents
-
view
217 -
download
0
Transcript of 9 Eurocare Lutz
-
7/29/2019 9 Eurocare Lutz
1/25
Survival in Europe (http://www.eurocare.it/
-
7/29/2019 9 Eurocare Lutz
2/25
EUROCARE
EUROPEAN CANCER REGISTRY BASED STUDY ONSURVIVAL AND CARE OF CANCER PATIENTS
EUROCARE is the widest collaborative research project on
cancer survival in Europe.The project started in 1989 under the initiative of tworesearch institutes, Istituto Nazionale Tumori (Milan, Italy)www.istitutotumori.mi.it and Istituto Superiore di Sanit(Rome, Italy) www.iss.it, with the participation of a largenumber of population-based Cancer Registries throughout
Europe.
-
7/29/2019 9 Eurocare Lutz
3/25
EUROCARE
EUROPEAN CANCER REGISTRY BASED STUDY ON
SURVIVAL AND CARE OF CANCER PATIENTS
Aims of the study wer and still are: to provide an updated
description of cancer survival time trends and differences
across European countries, to measure cancer prevalence,
and to study patterns of care of cancer patients.
-
7/29/2019 9 Eurocare Lutz
4/25
EUROCARE 1-4
Project Nb cases Nb CR's Nb cancer(period) / Nb countries sites
EUROCARE-1 800,000 30 / 12 27(1978 > 84)
EUROCARE-2 1,300.000 45 / 17 42(1985 > 89)
EUROCARE-3 1,800,000 56 / 22 42
(1990 > 94)
EUROCARE-4 2,900,000 90 / 22 44(1995-99 > 2002)
-
7/29/2019 9 Eurocare Lutz
5/25
EUROCARE-3 & 4
Geographiccoverage
22 countries90 CRs
UK (England, Scotland, Wales)Nordic countriesSouth and West EuropeEastern Europe
-
7/29/2019 9 Eurocare Lutz
6/25
-
7/29/2019 9 Eurocare Lutz
7/25
EUROCARE 5
The fifth and current edition, EUROCARE-5, includes dataon more than 21 million cancer diagnoses provided by 116Cancer Registries in 30 European countries.
Aims :
To update the existing EUROCARE data bank, byincluding data of patients diagnosed up to 2007. Follow upwill be updated to the most recent possible dates (e.g. on31/12/2008) in order to analyse both long and short termsurvival rates of cases diagnosed more recently.
To analyse survival of cancer patients by means ofconventional and more innovative methods: e.g. cohortrelative survival; period survival analysis to estimatesurvival of patients with recent diagnosis; mixture survivalmodel to estimate the proportion of patients cured.
-
7/29/2019 9 Eurocare Lutz
8/25
EUROCARE 5
To compare diagnostic and therapeutic procedures forcancer patients in Italy with those in other Europeancountries at high survival by means of high resolutionstudies (HR).
To increase and promote the use of cancer survivalregistry data. The EUROCARE results will be diffused amongthe medical, public health and scientific communities, tothe public in general, to tumour patients and to healthplanners.
-
7/29/2019 9 Eurocare Lutz
9/25
EUROCARE-5
Geographiccoverage
30 countries116 CRs
-
7/29/2019 9 Eurocare Lutz
10/25
Countries ranked by survival, colored according their TNEH*0 20 40 60 80 100
SWITZERLAND
SWEDEN
NORWAY
FINLAND
FRANCE
GERMANY
BELGIUM
NETHERLAND
ICELAND
AUSTRIA
ITALY
SPAIN
EU4 POOL
UK NORTH IRELAND
MALTA
UK SCOTLAND
PORTUGAL
IRELAND
UK WALES
UK ENGLAND
DENMARK
SLOVENIA
CZECH
POLAND
EUROCARE-4 1995-99Five-year Age Standardised Relative survivalAll cancers
* TNEH:
Total
NationalExpenditure
for Health
-
7/29/2019 9 Eurocare Lutz
11/25
All cancers combined (EUROCARE 4)
5-year age-adj. relative survival trend in male
8.5
7.5
10.5
6.7
12.1
6.6
8.9
8.8
6.3
7.9
9.2
8.7
4.5
7.2
5.2
3.5
6.6
-2.3
1.8
0 10 20 30 40 50 60
Iceland
Sweden
Swiss
Dutch
French
German
Norway
Finland
Spanish
Europe
Italian
English
Denmark
Wales
Scotland
Slovenia
Estonia
Slovakia
Polish
Relative survival
1984
1993 -1984
8.0
6.5
5.2
9.5
6.4
4.5
4.7
7.4
7.5
7.5
6.4
3.9
4.5
4.0
6.8
7.3
6.3
3.9
0 10 20 30 40 50 60
French
Swiss
Sweden
Dutch
Spanish
German
Finland
Iceland
Norvay
ItalianEurope
English
Slovenia
Wales
Scotland
Slovakia
Estonia
Polish
Relative survival
1984
1993 -1984
5-year age-adj. relative survival trend in female
-
7/29/2019 9 Eurocare Lutz
12/25
EUROCARE-4 1995-99Five-year Age Standardised Relative survivalcolorectum cancer
EUROCARE-4 1995-99
Five-year Age standardised survival by regions
0 20 40 60 80 100
DENMARK
FINLAND
ICELAND
NORWAY
SWEDEN
IRELAND
UK ENGLAND
UK NORTH IRELAND
UK SCOTLAND
UK WALES
AUSTRIA
BELGIUM
FRANCE
GERMANY
ITALY
MALTA
NETHERLAND
PORTUGAL
SPAIN
SWITZERLAND
CZECH
POLAND
SLOVENIA
EU4 POOL
C
o
l
o
r
e
c
t
um
countries grouped by region countries ranked by TNEH
five-year AAS by TNHE -colorecum
0 20 40 60 80 100
SWITZERLAND
GERMANY
NORWAY
ICELAND
FRANCE
DENMARK
BELGIUM
NETHERLAND
SWEDEN
AUSTRIA
ITALY
UK ENGLAND
UK NORTH IRELAND
UK SCOTLAND
UK WALES
MALTA
FINLANDIRELAND
SPAIN
PORTUGAL
CZECH
POLAND
SLOVENIA
EU4 POOL
-
7/29/2019 9 Eurocare Lutz
13/25
EUROCARE-4: 5-year survival of lung cancer patients
0 20 40 60 80 100
DENMARK
FINLAND
ICELAND
NORWAY
SWEDEN
IRELAND
UK ENGLAND
UK NORTH IRELAND
UK SCOTLAND
UK WALES
AUSTRIA
BELGIUM
FRANCE
GERMANY
ITALY
MALTA
NETHERLAND
PORTUGAL
SPAIN
SWITZERLAND
CZECH
POLAND
SLOVENIA
EU4 POOL
L
u
n
g
-
7/29/2019 9 Eurocare Lutz
14/25
EUROCARE-4: 5-year survival of breast cancer patients
0 20 40 60 80 100
DENMARKFINLAND
ICELAND
NORWAY
SWEDEN
IRELAND
UK ENGLAND
UK NORTH IRELAND
UK SCOTLAND
UK WALES
AUSTRIA
BELGIUM
FRANCE
GERMANY
ITALY
MALTA
NETHERLAND
PORTUGAL
SPAIN
SWITZERLAND
CZECH
POLAND
SLOVENIA
EU4 POOL
B
r
ea
s
t
-
7/29/2019 9 Eurocare Lutz
15/25
8588868581
7882
78 78 72
0
20
40
60
80
100
15-44 45-54 55-64 65-74 75-99
Age at diagnosis (years)
Relatives
urvival(%)
USA (SEER)
Europe (EUROCARE)
Breast cancer, five-year survival by ageUSA vs. Europe, women diagnosed 1990-94
-
7/29/2019 9 Eurocare Lutz
16/25
Relative excess risk of death of women diagnosed withbreast cancerin Europe (EUROCARE) vs. US (SEER), 1990-92
Model 1 Model 2 Model 3age
follow-up+
stage+
n examinednodes
SEER
EUROCARE
1
1.37*
1
1.12*
1
1.07
Age :
-
7/29/2019 9 Eurocare Lutz
17/25
0102030405060708090
100
83-85 86-88 89-91 92-94
Testis
OropharynxOvary
OesophagusLung
LiverPancreas
ThyroidCorpus
MelanomaBreast Hodgkin
,Bladder LarynxCervixProstateKidneyOralRectumNHL Colon
HypopharynxStomachBrain
EUROCARE : 5-year relative survival trends 1983-94
-
7/29/2019 9 Eurocare Lutz
18/25
The cancer survival gap between elderly andmiddle aged patients in Europe is widening
-
7/29/2019 9 Eurocare Lutz
19/25
The advantage of women in cancer survival
-
7/29/2019 9 Eurocare Lutz
20/25
The cure of cancer:A European perspective
-
7/29/2019 9 Eurocare Lutz
21/25
-
7/29/2019 9 Eurocare Lutz
22/25
12
3
4
5
7
6
-
7/29/2019 9 Eurocare Lutz
23/25
-
7/29/2019 9 Eurocare Lutz
24/25
-
7/29/2019 9 Eurocare Lutz
25/25